United StatesDoxazosin Tablets, USP 4 mg, 1000 tablets per bottle (NDC 29300-353-10), lot GDSH25006, exp 08/2027, distributed nationwide by Unichem Pharmaceuticals USA Inc., are affected. The product was recalled because tablets/capsules are imprinted with the wrong ID.
What's being recalled
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Recalling firm: Unichem Pharmaceuticals USA Inc., East Brunswick, NJ, United States.
How to identify it
Lot # GDSH25006, Exp Date: 08/2027
The hazard
Tablets/Capsules Imprinted with Wrong ID
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)